Search

Jul 01, 1996
An “Epidemic” of Medical Malpractice? A Commentary on the Harvard Medical Practice Study
Richard E. Anderson, MD, FACP, is chairman and CEO of The Doctors Company.
Both supporters and opponents of malpractice legal reform can agree that the Harvard study provides us with a wealth of valuable data on questions of medical negligence. More than with most studies, however, the Harvard group’s results are subject to sharply different interpretations and depend heavily on definitions and assumptions with which many will differ.

Litigation
Facing a medical malpractice lawsuit is one of the most trying experiences you encounter as a physician, adding to the pressures of an already demanding profession. These resources can help you master defense tactics, deliver sound testimony, and cope with the emotional stress.

February 21, 2024, Journal of the American College of Cardiology
Professional Liability: The Problem That Will Not Go Away
The frequency of malpractice claims in the United States has trended downward in the last 10 to 15 years, however, there is an upward trend in the “severity” of claims, driven in large part by “nuclear” jury verdicts. Cardiologists and other clinicians should always be aware that a lack of communication is a common causal factor in malpractice suits. Richard E. Anderson, MD, FACP, Chairman and CEO, The Doctors Company and TDC Group, investigates claim amounts and severity alongside three prominent physicians.

Mike Tungate
Mike Tungate is president of The Doctors Agency of Michigan.

Thomas Murphy
Tom Murphy is an agent for medical malpractice insurance with Danna-Gracey. He is based in Delray Beach, Florida.

Video Jul 29, 2024
Why Do Large Verdicts Influence the 1% of Cases We Lose and How Does This Effect MPL Rates?
In 2010, there were 18 nuclear verdicts totaling $10 million or more in the United States. By the end of 2023, there were 58 of these large verdicts, meaning there was at least one nuclear verdict occurring every week across the U.S. The bad news? 2024 is on pace to equal or surpass what transpired in 2023. Robert White, President of The Doctors Company and TDC Group, discusses how large verdicts are creating a domino effect on medical professional liability rates.

Professional Education
Alzheimer's 6: Pharmacological Management of Behavioral and Psychological Symptoms of Dementia
Join our self-paced educational program to learn to distinguish dementia symptoms from other psychiatric issues and treat them with pharmacological interventions. Improve recognition of behavioral problems in Alzheimer's and dementia patients, use the DICE psycho-behavioral model for medication decisions, and create treatment plans with behavioral and pharmacological strategies to refine your best practices for individuals with dementia. [1.50 AMA PRA Category 1 Credits™, 1.50 Contact Hours (ANCC)]

Stay in the Know

Sign up for The Doctor’s Practice.

Our e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe